Patterns of care and prognostic evaluation for stage I–III upper esophageal squamous cell carcinoma: a population-based studyDongbo Chen, Yichun Wang, Mingwei Yang et al.|Annals of Translational Medicine|2022Cited by 5
Assessing the effectiveness of camrelizumab plus apatinib versus sorafenib for the treatment of primary liver cancer: a single-center retrospective studyDongbo Chen, Liyang Zhu, Yichun Wang et al.|Scientific Reports|2023Cited by 3
Camrelizumab combined with apatinib in the treatment of patients with hepatocellular carcinoma: a real-world assessmentDongbo Chen, Kang Mei, Xiangxun Chen et al.|Neoplasma|2023Cited by 3
Neoadjuvant versus adjuvant chemoradiotherapy for esophageal carcinoma: a systematic review and meta-analysisLi Zhang, Liming Wu, Li Niu et al.|Annals of Esophagus|2021Cited by 0
Camrelizumab/apatinib vs. sorafenib as therapy for primary liver cancer: a retrospective study of a single CenterDongbo Chen, Liyang Zhu, Yichun Wang et al.|Research Square|2023Cited by 0